Updated for 2023! Care Step Pathways
These updates reflect the very latest management strategies for immune-related adverse event grading and management in 13 organ-specific working groups. New for 2023 includes the addition of a Care Step Pathway for myocarditis. Learn More
New! OPDUALAG™ (nivolumab)/(relatlimab) Resources Just released: The HCP Toolkit and Patient Action Plan for melanoma. Click Here for the Toolkit Click Here for the Action Plan New! Primer on Decision Making for Stage II Melanoma The primer covers common questions about Stage II melanoma, which Stage II patients are eligible for adjuvant therapy, and the pros and cons of adjuvant therapy vs active surveillance.

This resource should help you or your loved one, in conjunction with your oncology care team, make an informed decision about steps to take after surgery.
Learn More
Non-Invasive Evaluation Tools For Suspicious Spots New Melanoma Activity! Click Here to Learn More Stage IV Melanoma: Strategies to Support Shared Decision Making

A CME/CE Activity for Oncology Care Providers
New Interactive Activity! click here to learn more
Health Care Provider Resources for Optimizing IO Therapy AIM with Immunotherapy

Care Step Pathways

Step-by-step assessment and management guides for notable AEs associated with newer therapies

Provider Toolkit

Online and downloadable quick and easy resources to advance the care of immunotherapy patients

Printable Patient Materials

Educate and engage patients with information on specific therapies

HCP Videos

Video Portal: short side-effect management snippets


Stay up to date on immunotherapy patient care with free online education modules and events

Resources by Tumor Type

View all of the patient and provider resources by tumor type

JCO OP Supplement

JCO Oncology Practice uses cases to illustrate optimal multidisciplinary management of irAEs


Get the latest news on immunotherapy